Asthma drug 'linked to adverse events'

The asthma drug formoterol increases patients' risk of non-fatal serious adverse events, a Cochrane review suggests.

The review of 22 studies involving 8,032 patients looked at the risk of fatal and non-fatal serious adverse events for patients taking formoterol, compared with those given placebo or the short-acting beta-2 agonist salbutamol.

Formoterol is a long-acting beta-2 agonist, a class of medicines whose safety has been called into question previously.

Too few deaths occurred in the studies to assess any differences in the risk of fatal serious adverse events.

Non-fatal serious adverse events, however, were increased by 57 per cent in patients given formoterol compared with those on placebo. No significant increase in either fatal or non-fatal events was seen with salbutamol.

AstraZeneca, which manufactures Oxis and the combination product Symbicort, which contain formoterol, told GP that a recent review of 80,000 patients showed that formoterol-containing products reduced risk of serious adverse events.

The company believes this reflects real-life practice more accurately than the clinical trial data used in the Cochrane review.

It said it has sent the data to the Cochrane Collaboration.

Novartis, manufacturer of Foradil, which also contains formoterol, said that data from 10 million patient-years of exposure showed a positive benefit/risk ratio for formoterol. A spokesman said people should not stop taking medications unless advised to by a doctor.

Cochrane Library

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Just published

GP typing at computer

GP practices asked to switch on data sharing with UK Biobank

GP practices have been asked to share patient data with the biomedical database UK...

Child vaccination

'Serious concern' as child vaccination rates slip and MMR hits new low

Health officials have voiced 'serious concern' after child vaccination rates in England...

Talking General Practice logo

Podcast: GP contract trends, the future of physician associates, cost-of-living impact on patient health

The team discusses what recent tenders for GP contracts tell us about the possible...

GP consultation

GP practices delivering 150,000 extra appointments per day compared with 2019

GP practices in England delivered 150,000 more appointments per working day in the...

Surgeon looking at a monitor in an operating theatre

NICE recommends non-invasive surgical procedure to target obesity

NICE has said that a non-invasive weight loss procedure should be used by the NHS...

GP trainee

Two training posts deliver one full-time GP on average, report warns

Two training posts are needed on average to deliver a single fully-qualified, full-time...